Navigation Links
Cochrane Reviews in Peripheral Vascular Diseases

ProductsCochrane Reviews in Peripheral Vascular Diseases
Company Skyscape, Inc.
Item Cochrane Reviews in Peripheral Vascular Diseases
Features 
  • Cochrane Reviews have become known internationally as sources of high quality, reliable health information
  • A structured format helps the reader to find his/her way around the review quickly and easily
  • Multinational editorial teams try to ensure that a review is applicable in different parts of the world
  • Cochrane Reviews are updated quarterly
Description Cochrane Reviews enable all those involved with healthcare decisions to keep up to date with the very latest evidence in their field of interest - a challenge which becomes harder each year as the volume of evidence increases. Cochrane Reviews solve this problem by delivering the best single source available for continually updated evidence-based medical information. Each review explores the evidence for and against the effectiveness and appropriateness of treatments (medications, surgery, education, etc) in specific circumstances.
Info Skyscape, Inc.
Customer Service: 508-460-6500
Web site: http://www.skyscape.com/index/home.aspx

Related medicine products :

1. Cochrane Reviews in Wounds
2. Cochrane Reviews in Heart
3. Cochrane Reviews in Hypertension
4. Cochrane Reviews in Epilepsy
5. Cochrane Reviews in Movement Disorders
6. Cochrane Reviews in Multiple Sclerosis
7. Cochrane Reviews in Neuromuscular Disease
8. Cochrane Reviews in Stroke
9. Cochrane Reviews in Incontinence
10. Cochrane Reviews in Prostatic Diseases and Urologic Cancers
11. Cochrane Reviews in Back
Breaking Medicine Technology:Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10Over 74 000 Participate in President Obama Teleforum on Healthcare Reform 53015 1Over 74 000 Participate in President Obama Teleforum on Healthcare Reform 53015 2Caraco Pharmaceutical Laboratories Ltd Announces Change to Executive Team as Jitendra N Doshi Assumes Position of CEO 53013 1Caraco Pharmaceutical Laboratories Ltd Announces Change to Executive Team as Jitendra N Doshi Assumes Position of CEO 53013 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 1Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 3